Publications

1.     Kent DR 4th, Dey N, Davidson F, Gregoire F, Petterson KA, Goddard WA 3rd, and Roberts JD. An NMR and quantum mechanical investigation of solvent effects on conformational equilibria of butanedinitrile. Journal of the American Chemical Society 124(31): 9318-9322, 2002. PMID: 12149040. [original work]

2.     Furman MH, Dey N, Tortorella D, and Ploegh HL. The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. Journal of Virology 76(22): 11753-11756, 2002. PMID: 12388737. PMCID: PMC136774. [original work]

3.     Campos RA, Szczepanik M, Itakura A, Lisbonne M, Dey N, Leite-de-Moraes MC, and Askenase PW. Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity. Immunology 117: 536-547, 2006. PMID: 16556268. PMCID: PMC1382258. [original work]

4.     Dey N, Nazif TM, and Sharpe B. Stranded in San Francisco. Lancet 372(9642): 1008, 2008. PMID: 18790323. [case report]

5.     Dey N, Szczepanik M, Lau K, Majewska M, and Askenase PW. Stimulatory lipids accumulate in the mouse liver within 30 minutes of contact sensitization to facilitate activation of naïve iNKT cells in a CD1d-dependent yet hepatocyte-independent fashion. Scandinavian Journal of Immunology 74(1): 52-61, 2011. PMID: 21352253. [original work]

6.     Soergel D, Dey N, Knight R, and Brenner SE. Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences. ISME Journal 6:1440-1444, 2012. PMID: 22237546. PMCID: PMC3379642. [original work]

7.     Dey N, Soergel D, Repo S, and Brenner SE. Association of gut microbiota with post-operative clinical course in Crohn’s disease. BMC Gastroenterology 13:131, 2013. PMID: 23964800. PMCID: PMC3848607. [original work]

8.     Dey N, Wagner VE, Blanton LV, Cheng J, Fontana L, Haque R, Ahmed T, and Gordon JI. Regulators of Gut Motility Revealed
by a Gnotobiotic Model of Diet-Microbiome Interactions Related to Travel. Cell 163(1):95-107, 2015. PMID: 26406373. PMCID: PMC4583712. [original work]

9.     Vivio E, Kanuri N, Monroe K, Gilbertsen J, Dey N, Chen CH, Gutierrez AM, and Ciorba MA. Vedolizumab efficacy in IBD and safety over its first year in clinical practice. Journal of Crohn’s and Colitis 10(4):402-409, 2016. PMID: 26681763. PMCID: PMC4946762. [original work]

10.  Wagner VE*Dey N* (*co-first authors), Guruge J, Hsiao A, Ahern PP, Semenkovich NP, Blanton LV, Cheng J, Griffin N, Stappenbeck TS, Ilkayeva O, Newgard CB, Petri W, Haque R, Ahmed T, and Gordon JI.  Effects of a gut pathobiont in a gnotobiotic mouse model of childhood undernutritionScience Translational Medicine 8(366):366ra164, 2016. PMID: 27881825. PMCID: PMC5152673. [original work]

11.  Dey N, Ciorba MA. Probiotic Gut Bacteria Enhance Cancer Immunotherapy in a Mouse Model of Melanoma. Gastroenterology. 2016 Jul;151(1):206-7. 2016. PMID: 27238844. [selected summary]

12.  Camacho-Soto A, Gross A, Searles Nielsen S, Dey N, and Racette BA. Inflammatory bowel disease and risk of Parkinson’s disease in Medicare beneficiaries. Parkinsonism Related Disorders 50:23-28, 2018. PMID: 29459115. PMCID: PMC5943158. [original work]

13.  Dey N, Kochman ML, Komanduri S, Melson JE, and Muthusamy VR. Report from the AGA Center for GI Innovation and Technology’s Consensus Conference: Envisioning Next-Generation Paradigms in Colorectal Cancer Screening and Surveillance. Gastroenterology. 2019. PMID: 31525354. [meeting summary]

14.  Li S, Simoni Y, Becht E, Yee Loh C, Li N, Lachance D, Koo SL, Por Lim T, Kwong Wei Tan E, Mathew R, Nguyen A, Golovato J, Berkson JD, Prlic M, Lee B, Minot SS, Nagarajan N, Dey N, Tan DSW, Tan IB, Newell EW. Human tumor-infiltrating MAIT cells display hallmarks of bacterial antigen recognition in colorectal cancer. Cell Reports Medicine. 2020. PMID: 33205061. PMCID: PMC7659584. [original work]

15.  Melson JE, Imperiale TF, Itzkowitz SH, Llor X, Kochman ML, Grady WM, Schoen RE, Burke C, Shaukat A, Rabeneck L, Ladabaum U, Bresalier R, Spiegel B, Yee J, Wang T, Lieberman D, Komanduri S, Muthusamy VR, and Dey N. AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States. Clinical Gastroenterology and Hepatology. 2020. PMID: 32634626. [white paper]

16.  Koester ST, Li N, Lachance DM, Morella NM, and Dey N. Variability in digestive and respiratory tract Ace2 expression is associated with the microbiome. PLoS ONE 16, e0248730, 2021. PMID: 33725024. PMCID: PMC7963026. [original work]

17.  Li N, Koester ST, Lachance DM, Dutta M, Cui JY, and Dey N. Microbiome-encoded bile acid metabolism modulates colonic transit times. iScience 24(6):102508, 2021. PMID: 34142026. PMCID: PMC8188381. [original work]

18.  Koester ST, Li N, Lachance DM, and Dey N. Marker-based assays for studying gut transit in gnotobiotic and conventional mouse models. STAR Protocols. 2021. PMID: 34806048. PMCID: PMC8585659. [original work]

19.  Kamp K, Li N, Lachance DM, Saad K, Tolentino E, Yoo L, Heitkemper MM, Clark-Snustad K, Lee SD, and Dey N. Interpersonal variability in gut microbial calprotectin metabolism. Gastro Hep Advances. 2022;1:853–856. PMID: 36160305. PMCID: PMC9494624. [original work]

20.  Bean EM, Morella NM, and Dey N. Complete Genome Sequences of Two Bacteroides uniformis Bacteriophages. Microbiology Resource Announcements 2022;11:e00610-22. PMID: 36121235. PMCID: PMC9584325. [original work]

21.  Hanna M, Dey N, and Grady WM. Emerging Tests for Noninvasive Colorectal Cancer Screening. Clin Gastroenterol Hepatol 2022:S1542-3565(22)01173–9. [review] PMID: 36539002.

22.  Dey N. Picking up microbial clues in early-onset colorectal cancer. Gut 2022:gutjnl-2022-328427. PMID: 36323504. [commentary]

23.  Ueland K, Sanchez SC, Rillamas-Sun E, Shen H, Schattenkerk L, Garcia G, VanDoren M, Myers SA, Santiago-Torres M, Di C, Dey N, Guthrie KA, Yung R, Davidson NE, and Greenlee H. A digital health intervention to improve nutrition and physical activity in breast cancer survivors: Rationale and design of the Cook and Move for Your Life pilot and feasibility randomized controlled trial. Contemporary Clinical Trials 2022;123:106993. PMID: 36336249. [original work]

24.  Rashidi A, Koyama M, Dey N, McLean JS, and Hill GR. Colonization resistance is dispensable for segregation of oral and gut microbiota. BMC Medical Genomics 2023;16:31. PMID: 36814251. [original work]

25.  Kamp K, Clark-Snustad K, Yoo L, Winders S, Cain K, Levy RL, Dey N, Lee S, Keefer L, Heitkemper M. A Comprehensive Self-Management Intervention for Inflammatory Bowel Disease (CSM-IBD): Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols 2023. [original work]

26.  Koyama M, Hippe DS, Srinivasan S, Proll SC, Miltiadous O, Li N, Zhang P, Ensbey KS, Hoffman NG, Schmitdt C, Yeh AC, Minnie SA, Strenk SM, Fiedler TL, Hattangady N, Kowalsky J, Grady WM, Degli-Esposti MA, Varelias A, Clouston AD, van den Brink MRM, Dey N, Randolph TW, Markey KA, Fredricks DN, Hill GR. Intestinal Microbiota Controls Graft-versus-Host Disease Independent of Donor-Host Genetic Disparity. Immunity 2023 (in press). [original work]

27.  Rashidi A, Gem H, McLean JS, Kerns K, Dean DR, Dey N, and Minot S. (2024). Multi-cohort shotgun metagenomic analysis of oral and gut microbiota overlap in healthy adults. Sci Data 11, 75. 10.1038/s41597-024-02916-x. [original work]

28.  Koester ST, Li N, and Dey N. (2024). RET is a sex-biased regulator of intestinal tumorigenesis. Front. Gastroenterol. 2, 1323471. 10.3389/fgstr.2023.1323471. [original work]

29.  Koester ST, Chow A, Pepper-Tunick E, Lee P, Eckert M, Brenchley L, P. Gardner, N. Li, A. Schiffenbauer, R. Volochayev, N. Bayat, J. S. McLean, L. G. Rider, S. Shenoi, A. M. Stevens, and Dey N. (2024). Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis. Scientific Reports 16158 (2024). [original work]

30.  Stangis MM, Chen Z, Min J, Glass SE, Jackson JO, Radyk MD, Hoi XP, Brennen WN, Yu M, Dinh HQ, Coffey RJ, Shrubsole MJ, Chan KS, Grady WM, Yegnasubramanian S, Lyssiotis CA, Maitra A, Halberg RB, Dey N*, Lau KS* (*co-corresponding authors). The Hallmarks of Precancer. Cancer Discovery. 2024;14: 683-689. PubMed PMID: 38571435. [perspective]

31.  Minot SS, Li N, Srinivasan H, Ayers JL, Yu M, Koester S, Stangis MM, Dominitz J, Halberg RB, Grady WM, and Dey N (2024). Colorectal cancer-associated bacteria are broadly distributed in global microbiomes and drivers of precancerous change. Scientific Reports 14, 23646 (2024). [original work]

32.  Kamp K, Clark-Snustad K, Saad K, Tolentino E, Heitkemper M, Dey N, Gui S, Lee SD. Correlation of fecal, plasma, serum, and salivary calprotectin to endoscopic and histologic outcomes in patients with Crohn’s disease. Gastroenterology Nursing (in press). [original work]

33. Gupta A, Morella N, Sutormin D, Li N, Gaisser K, Robertson A, Ispolatov Y, Seelig G, Dey N, Kuchina A. Combinatorial phenotypic landscape enables bacterial resistance to phage infection. bioRxiv [Preprint]. 2025 Jan 14:2025.01.13.632860. doi: 10.1101/2025.01.13.632860. PMID: 39868116; PMCID: PMC11761130. 

 

 

Publications above may not be up-to-date. Visit PubMed to view Dr. Neelendu Dey's complete publications record.